Tags:Science & TechUPSC
Source:Indian Express
Subject: Health, Social Sector and Non-Communicable Diseases|Target exams: UPSC
Key points for Prelims: Type 1 diabetes, Human insulin, Continuous glucose monitor, Glycated haemoglobin (HbA1c) test, World Health Organization
Mains syllabus mapping
- General Studies Paper 2: Health: issues relating to diseases, non-communicable diseases, access to health services and medicines
- General Studies Paper 2: Role of international organisations such as WHO in health governance
Key facts for one-day exams
- WHO issued its first guidelines for adult type 1 diabetes diagnosis and management.
- The access goal for affordable insulin and blood glucose self-monitoring is 2030.
- Approximately 500,000 people were diagnosed with type 1 diabetes globally in 2025.
- Type 1 diabetes is an autoimmune condition that causes a lack of insulin.
- WHO headquarters is in Geneva, Switzerland.
WHO type 1 diabetes guidelines: why in the news?
The WHO has published its first-ever guidelines for diagnosing and managing type 1 diabetes in adults, setting a 2030 target for affordable insulin and glucose monitoring access. This matters because type 1 diabetes, often seen as a childhood condition, is increasingly affecting adults, and many lack access to essential treatment.
The World Health Organization has issued its first-ever guidelines for diagnosing and managing type 1 diabetes in adults, the agency announced. The guidelines aim to ensure that people with type 1 diabetes have access to affordable insulin treatment and blood glucose self-monitoring by 2030. An estimated 9.5 million people lived with type 1 diabetes globally in 2025, with another 500,000 diagnosed that year, WHO noted.
Dr Søren Brostrøm, WHO Director of Noncommunicable Diseases and Mental Health, said in a statement that while insulin is a lifesaving treatment discovered more than 100 years ago, many people with type 1 diabetes still lack access to affordable, high-quality insulin. The new guidelines recommend that people with type 1 diabetes receive insulin injections several times a day, with doses adjusted to blood glucose levels. Human insulin is an appropriate and effective option, and other types can be used when needed, Dr Brostrøm said.
The guidelines also recommend regular monitoring of blood glucose levels. At clinics, this can include a regular blood test that shows average blood sugar levels over the past few months. At home, people can check their own levels with a finger-prick test or a continuous glucose monitor, a small sensor worn on the skin. Where blood glucose testing is not available, urine glucose testing can be considered, the guidelines state.
Why adult type 1 diabetes needs separate attention
Type 1 diabetes is an autoimmune condition that causes a lack of insulin. Although commonly associated with children, it can develop at any age. Dr Vijay Negalur, HoD of diabetology at KIMS Hospitals, Thane, told indianexpress.com that symptoms such as increased thirst, frequent urination, unexplained weight loss and persistent fatigue can be warning signs in adults. Greater awareness among patients and healthcare professionals can help ensure timely evaluation and the right diagnosis, as delayed recognition can postpone essential insulin treatment.
What the guidelines recommend for monitoring and treatment
The WHO guidelines recommend multiple daily insulin injections with doses adjusted to blood glucose levels. Regular monitoring supports day-to-day treatment decisions, while clinical blood tests reflecting average glucose over preceding months help assess the treatment plan. The recommendations are intended to support care even in resource-limited settings and where health services are disrupted. In India, experts have identified priorities including affordable insulin, accessible glucose monitoring, structured diabetes education and prevention of life-threatening complications, with access to continuous glucose monitors and insulin pumps remaining a challenge.
What is the 2030 access goal
The WHO has set a target of access to affordable insulin treatment and blood glucose self-monitoring for people with type 1 diabetes by 2030. Dr Rajiv Kovil, a diabetes and obesity specialist at Zandra Healthcare, told indianexpress.com that while newer technologies such as continuous glucose monitors and insulin pumps are transforming diabetes management, access remains a major challenge. He noted that insulin was discovered over 100 years ago, and the challenge in 2026 is no longer scientific discovery alone but ensuring that no person with type 1 diabetes is denied survival because of cost.
Key terms
- Type 1 diabetes:
- An autoimmune condition in which the body lacks insulin because insulin-producing cells are destroyed.
- Insulin:
- A hormone that helps regulate the level of glucose in the blood.
- Continuous glucose monitor:
- A device using a small sensor worn on the skin to monitor glucose levels continuously.
- World Health Organization:
- The United Nations specialised agency responsible for international public health.
WHO type 1 diabetes guidelines: why it matters for exams
Exams: UPSC
Syllabus: Science and Technology: Human health and diseases; Society: Public health and healthcare access
Common mistake: Examiners may present type 1 diabetes as a condition confined to children; it can develop at any age, including adulthood.
Mains practice questions
Question 1(GS-2 | 250 words | 15 marks)
Type 1 diabetes, long considered a childhood condition, is now affecting adults in growing numbers, yet many patients lack affordable insulin and glucose monitoring. Critically examine the challenges in ensuring universal access to insulin and glucose self-monitoring in developing countries like India, and suggest measures to address them.
Answer outline
- Introduction: Open by noting that WHO's first adult type 1 diabetes guidelines set a 2030 target for affordable insulin and glucose monitoring, highlighting the gap between a lifesaving discovery over a century old and its availability today.
- Body:
- Rising burden: type 1 diabetes is being diagnosed in adults as well as children, with about 500,000 new diagnoses globally in 2025 and roughly 9.5 million people living with the condition.
- Affordability and supply barriers: high prices of insulin, dependence on imports, cold-chain requirements and irregular supply in public health systems limit access.
- Diagnostic and monitoring gaps: unavailability of HbA1c tests and continuous glucose monitors outside urban private hospitals, and reliance on urine glucose testing where blood testing is absent.
- Health system and awareness issues: shortage of endocrinologists, poor adult diagnosis awareness, and out-of-pocket expenditure pushing families into financial hardship.
- Policy measures: strengthening the National Programme for Prevention and Control of Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), local manufacturing and price regulation of insulin, inclusion of CGMs and insulin in essential medicine lists, and public-private partnerships.
- Conclusion: Achieving the WHO's 2030 goal requires a balanced approach that combines affordable domestic production, equitable public procurement and integration of diabetes care into primary health services, so that insulin remains a right and not a privilege.
Stuck? Get it in one tap
Type 1 diabetes causes the body to lack insulin, a hormone that helps regulate blood glucose. WHO recommends insulin treatment and regular glucose monitoring for adults with the condition. The guidelines also seek to improve access to affordable treatment and monitoring.
- Science and Technology: Human health and diseases
- Society: Public health and healthcare access
Related concepts: Type 1 diabetes, Insulin, Continuous glucose monitor, World Health Organization
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
Which organisation issued the first guidelines for diagnosing and managing type 1 diabetes in adults?
Explanation: The World Health Organization issued the adult type 1 diabetes guidelines. Experts associated with Zandra Healthcare and KIMS Hospitals discussed their implications rather than issuing them.
- Q2Hard
Consider the following statements about the WHO adult type 1 diabetes guidelines:
- 1.Human insulin is an appropriate and effective treatment option.
- 2.Urine glucose testing can be considered where blood glucose testing is unavailable.
- 3.Type 1 diabetes develops only in childhood.
Which of the statements given above is/are correct?
Explanation: Statements 1 and 2 are correct: human insulin is an effective option, and urine testing may be considered when blood testing is unavailable. Statement 3 is incorrect because type 1 diabetes can develop at any age.
- Q3Medium
Approximately how many people lived with type 1 diabetes globally in 2025, according to WHO?
Explanation: WHO estimated that around 9.5 million people lived with type 1 diabetes globally in 2025. Approximately 500,000 additional people were diagnosed during that year.
- Q4Medium
Why is regular glucose monitoring important in managing adult type 1 diabetes?
Explanation: Glucose monitoring helps patients and clinicians understand changing levels and assess treatment. Monitoring complements insulin and clinical assessments rather than replacing them; type 1 diabetes can also develop in adults.
Frequently asked questions
1. What is the 2030 goal for people with type 1 diabetes?
The goal is access to affordable insulin treatment and blood glucose self-monitoring by 2030.
2. Can type 1 diabetes develop in adults?
Yes. Type 1 diabetes can develop at any age, so symptoms in adults require timely evaluation.
3. How can adults with type 1 diabetes monitor glucose levels?
Finger-prick tests and continuous glucose monitors can be used at home. Urine glucose testing can be considered where blood glucose testing is unavailable.
4. How many people lived with type 1 diabetes globally in 2025?
Around 9.5 million people lived with type 1 diabetes globally in 2025.
All sources
Original16 November 2026 · Read story

